Lindsey Byrne

This researcher's work focuses on inherited genetic risk in cancer, particularly examining hereditary syndromes such as BAP1 tumor predisposition syndrome, germline testing in prostate cancer, and polygenic risk scores for cancer screening. The research spans genetic counseling implementation, clinical genetics of rare tumor syndromes (renal cell carcinoma, uveal melanoma, meningioma), and practical barriers to genetic testing in oncology care. Note that a few listed publications concern astrophysics topics (circumgalactic medium, black hole growth simulations) which appear unrelated to this researcher's main cancer genetics work and may reflect a data or name-matching issue.

Publication output has grown substantially over the last decade, rising from sporadic single papers in the late 2010s to a sustained higher rate of 6-10 papers per year since 2022.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026